Arihant Capital Reports Strong Q2 FY27 Results and Evaluates Fundraising Plans
Arihant Capital Markets Ltd · Outcome · 31 Oct 2026, 12:38 am
Arihant Capital Reports Strong Q2 FY27 Results and Evaluates Fundraising Plans Arihant Capital Markets reported consolidated net profit of ₹2,090.19 lacs for Q2 ended 30th Sep'26, surging 59.7% YoY from ₹1,308.37 lacs, despite declining 2.7% QoQ. Consolidated revenue from operations grew 33.1% YoY to ₹7,581.81 lacs, supported by higher net gains on fair value changes and steady fee income. For H1 ended 30th Sep'26, consolidated net profit surged 64.4% YoY to ₹4,239.12 lacs. Additionally, the board discussed various fundraising options to strengthen capital base and support future expansion.
Original exchange filing (PDF)
More announcements from Arihant Capital Markets Ltd
- ARIHANT CAPITAL MARKETS LIMITED has informed the Exchange about Board Meeting to be held on 18-Nov-2026 to consider Other business. · 11 Nov 2026
- Arihant Capital Markets Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/11/2026 ,inter alia, to consider and approve To consider and approve .... · 11 Nov 2026
- Intimation of In-principle approval from SEBI for sponsoring / setting up of Mutual Fund · 06 Nov 2026
- Arihant Capital Markets Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 31 Oct 2026
- Submission of Unaudited standalone and consolidated financial results for the quarter and half year ended on September 30, 2026 · 31 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 30 Oct 2026
- ARIHANT CAPITAL MARKETS LIMITED has informed the Exchange about Board Meeting to be held on 30-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 30 Oct 2026
- Arihant Capital Markets Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve Standalone and Consolidated .... · 30 Oct 2026
